Description
Methox 10 mg is a pharmaceutical preparation containing methotrexate, a potent antimetabolite and immunosuppressive agent. It is primarily indicated for the treatment of various neoplastic diseases, including gestational choriocarcinoma, chorioadenoma destruens, hydatidiform mole, acute lymphoblastic leukemia, and advanced stages of non-Hodgkin’s lymphomas. Additionally, Methox is utilized in the management of certain types of cancer such as breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous T-cell lymphoma), and lung cancer, particularly squamous cell and small cell types.
.jpg)
Change Language